Inventor · disambiguated record
Gordon B. Mills
Also filed as: MILLS GORDON · MILLS GORDON B
22 granted patents·24 pending applications·589 citations·filing 1992–2023
96Inventor score
Top patents by PatentIndex Score
46 records- 0196US10640816B2Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissueNANOSTRING TECHNOLOGIES INC·Filed 2016·Granted May 5, 2020·161 cites·39 claims
- 0296US10501777B2Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissueNANOSTRING TECHNOLOGIES INC·Filed 2016·Granted Dec 10, 2019·125 cites·39 claims
- 0396US7494775B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2005·Granted Feb 24, 2009·59 cites·9 claims
- 0495US8323906B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerVEIBY OLE PETTER·Filed 2008·Granted Dec 4, 2012·73 cites·14 claims
- 0593US6355618B1Caspase inhibitors and the use thereofCYTOVIA INC·Filed 2000·Granted Mar 12, 2002·45 cites·42 claims
- 0688US6566338B1Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell deathCYTOVIA INC·Filed 2000·Granted May 20, 2003·31 cites·19 claims
- 0787US6716818B2Caspase inhibitors and the use thereofCYTOVIA INC·Filed 2001·Granted Apr 6, 2004·22 cites·41 claims
- 0886US6495522B1Substituted alpha-hydroxy acid caspase inhibitors and the use thereofCYTOVIA INC·Filed 2000·Granted Dec 17, 2002·31 cites·170 claims
- 0982US11708602B2Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissueNANOSTRING TECHNOLOGIES INC·Filed 2019·Granted Jul 25, 2023·1 cites·20 claims
- 1080US10533227B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2015·Granted Jan 14, 2020·2 cites·24 claims
- 1179US11447830B2Gene signatures to predict drug response in cancerUNIV TEXAS·Filed 2018·Granted Sep 20, 2022·2 cites·30 claims
- 1277US2024167083A1Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissueNANOSTRING TECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 1371US12435361B2Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissueBRUKER SPATIAL BIOLOGY INC·Filed 2019·Granted Oct 7, 2025·0 cites·20 claims
- 1468US7871775B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMILLENNIUM PHARM INC·Filed 2007·Granted Jan 18, 2011·0 cites·4 claims
- 1567US8211646B1Methods of treating ovarian cancer by modulating SnoNNANJUNDAN MEERA·Filed 2009·Granted Jul 3, 2012·2 cites·12 claims
- 1666US9850542B2Gene signature to predict homologous recombination (HR) deficient cancerUNIV TEXAS·Filed 2014·Granted Dec 26, 2017·1 cites·8 claims
- 1765US2008311573A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1858US7074911B2Endogenous granzyme B in non-immune cellsUNIV TEXAS·Filed 2003·Granted Jul 11, 2006·0 cites·14 claims
- 1958US2013102482A1Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 2055US8404829B2Predictive and therapeutic markers in ovarian cancerGRAY JOE W·Filed 2006·Granted Mar 26, 2013·1 cites·3 claims
- 2155US2012141604A1Novel compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2011·Application pending·0 cites
- 2255US2004116355A1Caspase inhibitors and the use thereofCYTOVIA INC·Filed 2003·Application pending·0 cites
- 2354US2003087250A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2454US2005214831A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2553US2009136961A1Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2650US2003181388A1Substituted 2-aminobenzamide caspase inhibitors and the use thereofCYTOVIA INC·Filed 2003·Application pending·0 cites
- 2750US2010291068A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 2850US2007190550A1Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancersUNIV TEXAS·Filed 2006·Application pending·0 cites
- 2949US2010204125A1Genetic alterations associated with cancerUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
- 3048US7670767B1Genetic alterations associated with cancerUNIV CALIFORNIA·Filed 1997·Granted Mar 2, 2010·8 cites·3 claims
- 3147US5994141AMethod of detecting gynecological carcinomasCLEVELAND CLINIC FOUNDATION·Filed 1998·Granted Nov 30, 1999·12 cites·8 claims
- 3247US2008108091A1Proteomic Patterns of Cancer Prognostic and Predictive SignaturesHENNESSY BRYAN T·Filed 2007·Application pending·0 cites
- 3346US8080368B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2010·Granted Dec 20, 2011·0 cites·10 claims
- 3446US2022047596A1Combination of parp inhibitor and brd4 inhibitor for the treatment of cancerUNIV TEXAS·Filed 2019·Application pending·0 cites
- 3546US2023103330A1Mechanistic biomarker for predicting the survival of pancreatic cancer patientsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3645US7470509B2Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2003·Granted Dec 30, 2008·0 cites·19 claims
- 3745US6503755B1Particle transfection: rapid and efficient transfer of polynucleotide molecules into cellsKEATING ARMAND·Filed 1992·Granted Jan 7, 2003·13 cites·13 claims
- 3845US2004137541A1Method for detecting cancer associated with elevated concentrations of lysophospholipidsFiled 2003·Application pending·0 cites
- 3944US2023340605A1Biomarkers predicting clinical response of a vegf-a inhibitory drug in cancer patients, method for their selection and useUNIV OSLO HF·Filed 2021·Application pending·0 cites
- 4043US2016122825A1Efficient functional genomics platformUNIV TEXAS·Filed 2013·Application pending·0 cites
- 4142US2003113928A1Method of detecting gynecological carcinomasFiled 2002·Application pending·0 cites
- 4242US2002150955A1Method for detecting cancer associated with elevated concentrations of lysophospholipidsFiled 2002·Application pending·0 cites
- 4341US2002182619A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4441US2002123084A1Method for detecting cancer associated with elevated concentrations of lysophospholipidsFiled 2002·Application pending·0 cites
- 4540US2008071116A1Modulators of Lysophosphatidic Acid (Lpa) Signaling and the Use ThereofUNIV TEXAS·Filed 2004·Application pending·0 cites
- 4637US2009221440A1Methods and compositions related to identifying protein-protein interactionsUNIV TEXAS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gordon B. Mills files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →